Private Advisor Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-73,232
| Closed | -$3.31M | – | 1923 |
|
|
2022
Q2 | $3.31M | Sell |
73,232
-108
| -0.1% | -$4.88K | 0.03% | 548 |
|
|
2022
Q1 | $3.73M | Buy |
73,340
+98
| +0.1% | +$4.98K | 0.03% | 553 |
|
|
2021
Q4 | $3.46M | Sell |
73,242
-72,626
| -50% | -$3.43M | 0.03% | 592 |
|
|
2021
Q3 | $4.81M | Buy |
145,868
+74,673
| +105% | +$2.46M | 0.03% | 535 |
|
|
2021
Q2 | $4.5M | Buy |
71,195
+68
| +0.1% | +$4.3K | 0.04% | 440 |
|
|
2021
Q1 | $3.05M | Buy |
71,127
+37
| +0.1% | +$1.59K | 0.03% | 545 |
|
|
2020
Q4 | $4.07M | Buy |
71,090
+565
| +0.8% | +$32.3K | 0.04% | 397 |
|
|
2020
Q3 | $2.3M | Sell |
70,525
-956
| -1% | -$31.2K | 0.03% | 513 |
|
|
2020
Q2 | $2.33M | Buy |
71,481
+85
| +0.1% | +$2.78K | 0.03% | 483 |
|
|
2020
Q1 | $1.91M | Sell |
71,396
-2,387
| -3% | -$64K | 0.04% | 456 |
|
|
2019
Q4 | $2.26M | Sell |
73,783
-14,096
| -16% | -$432K | 0.04% | 489 |
|
|
2019
Q3 | $2.21M | Buy |
87,879
+45,229
| +106% | +$1.14M | 0.03% | 503 |
|
|
2019
Q2 | $1.08M | Buy |
+42,650
| New | +$1.08M | 0.02% | 710 |
|
|
2019
Q1 | – | Sell |
-14,150
| Closed | -$187K | – | 1540 |
|
|
2018
Q4 | $187K | Buy |
+14,150
| New | +$187K | ﹤0.01% | 1222 |
|